Reply to Correspondence by Calugaru and Calugaru to the Article Entitled "Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion" by Khayat et al

Affiliations

¹ Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, Northern Ireland, UK.
² Centre for Medical Education, Queen's University, Belfast, Northern Ireland, UK.
³ Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, Northern Ireland, UK. Electronic address: n.lois@qub.ac.uk.

Comment

Meiaad Khayat et al. Surv Ophthalmol. 2019 Jul-Aug.

. 2019 Jul-Aug;64(4):593-594.

doi: 10.1016/j.survophthal.2019.01.004. Epub 2019 Jan 23.

¹ Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, Northern Ireland, UK.
² Centre for Medical Education, Queen's University, Belfast, Northern Ireland, UK.
³ Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, Northern Ireland, UK. Electronic address: n.lois@qub.ac.uk.

No abstract available

Comment on

Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.
Khayat M, Williams M, Lois N. Khayat M, et al. Surv Ophthalmol. 2018 Nov-Dec;63(6):816-850. doi: 10.1016/j.survophthal.2018.04.005. Epub 2018 Apr 27. Surv Ophthalmol. 2018. PMID: 29705175 Review.
Ischemic retinal vein occlusion: Characterizing the more severe spectrum of retinal vein occlusion.
Călugăru D, Călugăru M. Călugăru D, et al. Surv Ophthalmol. 2019 May-Jun;64(3):440-441. doi: 10.1016/j.survophthal.2019.01.006. Epub 2019 Jan 28. Surv Ophthalmol. 2019. PMID: 30703403 No abstract available.